£30k award for international 3Rs prize
Each year the NC3Rs awards a prize, sponsored by GlaxoSmithKline, to highlight an outstanding original contribution to scientific and technological advances in the 3Rs, published in the last three years. The award consists of a £28k prize grant and £2k personal award. Highly-commended entries receive a £4k grant and a £1k personal award.
This year's competition is now closed.
For further information on the 3Rs prize, please contact 3Rsprize@nc3rs.org.uk
The 3Rs prize is for a piece of primary research published in a peer-reviewed journal in the last three years and is open to any researcher, in academia or industry. The prize is awarded to the principal investigator, research team leader, or other nominated author. The competition is open to international groups.
Applications are assessed by a dedicated Panel, which also selects the winner. Selection is based on the quality of the published research and its impact on the 3Rs.
Applications are welcomed from any research establishment, from academia or industry. Establishments outside of the UK are also eligible to apply.
Journal papers that contain primary research that advances or has the potential to advance the 3Rs are eligible. The work must have been published in a peer reviewed journal between 1 September 2014 and 1 September 2017. Papers that are in press by 1 September 2017 will also be considered.
A 3Rs prize nomination form should be completed with the research paper attached and emailed to 3Rsprize@nc3rs.org.uk. Nominations are welcome from anyone who is familiar with the research paper - e.g. lead or other author, head of department, journal editor or colleagues. The candidate nominated for the prize should normally be the lead author of the paper. In cases where the 3Rs aspects of the work were carried out by another author, the lead author can delegate the nomination. Entries are limited to one per individual or research group.
The deadline for the 2017 competition was 4pm (GMT) on Monday 4 December 2017.
Guidance on completing the nomination form is available.
Entries are assessed by the 3Rs prize Selection Panel based on:
- Whether it has advanced an area of research
- Impact on the 3Rs
- How well the 3Rs implications have been disseminated
- Whether the proposal for using the prize grant supports further development of the 3Rs.
|Member name||Institution||Term Ends|
University of Southampton
University of Nottingham
|Dr Melanie Graham||
University of Minnesota
|University of Guelph||2021|
Medical Research Council
|Mr Mike Turner||Wellcome Trust||
Biotechnology and Biological Sciences Research Council
|Professor Maurice Whelan||European Commission Joint Research Centre/ EURL ECVAM||2019|
Declarations of interest
Panel members are required to declare any private, professional or commercial interests that might, or that might be perceived to, conflict with the NC3Rs interests.